Genetic intratumour heterogeneity in digestive high‐grade neuroendocrine neoplasms
Journal of Neuroendocrinology · 2026-10 · 38 (10)
DOI: 10.1111/jne.70296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 18.10.2026. Verfasst von Siren Morken und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Clinic, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Genetic Heterogeneity, Digestive System Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Western Norway Regional Health Authority, Nordic Cancer Union, Novartis.
Abstract (Originalsprache)
Digestive high‐grade neuroendocrine neoplasms (HG‐NEN) are rare and heterogeneous tumours with an aggressive biology and limited treatment efficacy. Genetic intratumour heterogeneity (ITH) is a mechanism of progression and treatment resistance in other cancers, yet unexplored in digestive HG‐NEN. Next‐generation sequencing with a 360‐cancer gene panel was performed on 51 digestive HG‐NEN, suitable for multiregional sampling. The mutational status of each sample within a patient was assessed to calculate an ITH‐index, defined as the average number of discordant mutations across all pair‐wise comparisons between samples. An ITH‐index based on primary tumour samples was calculated for chemotherapy‐naïve cases: 28 neuroendocrine carcinomas (NEC), 9 mixed neuroendocrine‐non‐neuroendocrine neoplasms (MiNEN) and 3 neuroendocrine tumour grade 3 (NET G3). Median ITH‐index in NEC/MiNEN was 5, with a wide range (0–98.8). Greater heterogeneity was associated with right‐sided colonic primaries ( p = .005) and higher tumour mutational burden ( r = 0.74, p < .001). Median overall survival was 7 months longer in NEC/MiNEN with median ITH‐index above compared to below median (22.5 vs. 15.5 months, p = .077), driven mostly by patients with locoregional disease. Response to first‐line chemotherapy was not influenced by median ITH‐index. No heterogeneity was found among driver mutations in BRAF and KRAS . NET G3 displayed low heterogeneity (ITH‐index 2–3). Higher ITH‐index was not associated with shorter survival or treatment response, suggesting that genetic ITH is not the primary resistance mechanism in digestive NEC/MiNEN. Moving towards targeted treatment strategies, our data indicate that a single biopsy may underestimate ITH. BRAF and KRAS may be favourable targets as they displayed no heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Clinic, Haukeland University Hospital, Bergen, Norway.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
- Department of Oncology, University Hospital of Southern Denmark, Esbjerg, Denmark.
- Department of Oncology, Odense University Hospital, Odense, Denmark.
- Department of Oncology, Oslo University Hospital, Oslo, Norway.
- Department of Research, Hospital of Southern Norway, Kristiansand, Norway.
ORCID-Profile: Siren Morken, Halfdan Sorbye, Wei Deng, Hatice Toprak Dogramaci, Geir Olav Hjortland, Eva Hofsli, Hege Elvebakken, Anne Couvelard, Aurel Perren, Stian Knappskog
Förderung
- The Western Norway Regional Health Authority
- Nordic Cancer Union
- Novartis
- Ipsen
- Norwegian Cancer Society
- Kreftforeningen
Zitieren
APA
Morken, S., Sorbye, H., Deng, W., Dogramaci, H. T., Venizelos, A., Vestermark, L. W., Pfeiffer, P., Hjortland, G. O., Kersten, C., Hofsli, E., Elvebakken, H., Couvelard, A., Lothe, I. M. B., Perren, A., & Knappskog, S. (2026). Genetic intratumour heterogeneity in digestive high‐grade neuroendocrine neoplasms. Journal of Neuroendocrinology, 38(10). https://doi.org/10.1111/jne.70296
Vancouver
Morken S, Sorbye H, Deng W, Dogramaci HT, Venizelos A, Vestermark LW, et al. Genetic intratumour heterogeneity in digestive high‐grade neuroendocrine neoplasms. Journal of Neuroendocrinology. 2026;38(10). doi:10.1111/jne.70296
BibTeX
@article{Morken2026,
author = {Morken, Siren and Sorbye, Halfdan and Deng, Wei and Dogramaci, Hatice Toprak and Venizelos, Andreas and Vestermark, Lene Weber and Pfeiffer, Per and Hjortland, Geir Olav and Kersten, Christian and Hofsli, Eva and Elvebakken, Hege and Couvelard, Anne and Lothe, Inger Marie Bowitz and Perren, Aurel and Knappskog, Stian},
title = {Genetic intratumour heterogeneity in digestive high‐grade neuroendocrine neoplasms},
journal = {Journal of Neuroendocrinology},
year = {2026},
volume = {38},
number = {10},
doi = {10.1111/jne.70296}
}
EUVIMED